Compare SCLX & STEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | STEM |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.3M | 120.1M |
| IPO Year | N/A | N/A |
| Metric | SCLX | STEM |
|---|---|---|
| Price | $17.70 | $17.62 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $14.60 |
| AVG Volume (30 Days) | 119.6K | ★ 177.3K |
| Earning Date | 11-14-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $40,360,000.00 | ★ $164,948,000.00 |
| Revenue This Year | N/A | $3.43 |
| Revenue Next Year | $749.70 | $12.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.60 | $5.81 |
| 52 Week High | $34.27 | $33.60 |
| Indicator | SCLX | STEM |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 50.49 |
| Support Level | $18.34 | $16.57 |
| Resistance Level | $20.62 | $19.34 |
| Average True Range (ATR) | 2.14 | 1.32 |
| MACD | -0.28 | 0.40 |
| Stochastic Oscillator | 1.86 | 74.79 |
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.